Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Ravuconazole is a new antifungal triazole with broad-spectrum activity and a long half-life in plasma. We studied the antifungal efficacy, safety, and pharmacokinetics of ravuconazole lysine phosphoester in escalating dosages for the treatment of invasive pulmonary aspergillosis due to Aspergillus f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Petraitiene, Ruta, Petraitis, Vidmantas, Lyman, Caron A., Groll, Andreas H., Mickiene, Diana, Peter, Joanne, Bacher, John, Roussillon, Kristin, Hemmings, Melissa, Armstrong, Derrek, Avila, Nilo A., Walsh, Thomas J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2004
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC375262/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15047519/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.4.1188-1196.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars